NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 7BSL designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 7BSL_NAD_A_602 | 8% | 46% | 0.336 | 0.83 | 0.81 | 1.17 | 1 | 5 | 0 | 0 | 100% | 1 |
| 7BSL_NAD_B_602 | 7% | 42% | 0.307 | 0.781 | 0.86 | 1.29 | 3 | 6 | 0 | 0 | 100% | 1 |
| 7BSL_NAD_B_601 | 4% | 43% | 0.374 | 0.782 | 0.84 | 1.25 | 1 | 5 | 1 | 0 | 100% | 1 |
| 7BSL_NAD_A_601 | 2% | 43% | 0.358 | 0.682 | 0.84 | 1.25 | 1 | 7 | 0 | 0 | 100% | 1 |
| 9AYI_NAD_A_605 | 93% | 60% | 0.063 | 0.966 | 0.65 | 0.73 | - | 1 | 0 | 0 | 100% | 1 |
| 1PJ3_NAD_C_2601 | 85% | 22% | 0.096 | 0.967 | 1.86 | 1.3 | 11 | 2 | 1 | 0 | 100% | 1 |
| 9MYF_NAD_A_604 | 80% | 65% | 0.081 | 0.934 | 0.6 | 0.59 | - | - | 1 | 0 | 100% | 1 |
| 7BSJ_NAD_A_601 | 58% | 42% | 0.145 | 0.925 | 0.9 | 1.24 | 3 | 6 | 1 | 0 | 100% | 1 |
| 7BSK_NAD_A_602 | 43% | 45% | 0.199 | 0.926 | 0.84 | 1.18 | 3 | 6 | 0 | 0 | 100% | 1 |
| 3CMC_NAD_R_408 | 100% | 19% | 0.016 | 0.998 | 1.63 | 1.74 | 4 | 9 | 0 | 0 | 100% | 1 |
| 4RQU_NAD_B_403 | 100% | 3% | 0.019 | 0.997 | 3.51 | 2.61 | 13 | 18 | 0 | 0 | 100% | 1 |
| 2O2Y_NAD_D_550 | 100% | 17% | 0.023 | 0.996 | 1.65 | 1.87 | 4 | 9 | 0 | 0 | 100% | 1 |
| 2BJK_NAD_A_1517 | 100% | 55% | 0.025 | 0.995 | 0.72 | 0.86 | - | 1 | 1 | 0 | 100% | 0.86 |
| 3EC7_NAD_A_400 | 100% | 17% | 0.025 | 0.995 | 1.8 | 1.74 | 5 | 8 | 1 | 0 | 100% | 1 |
